Sterigenics, a Subsidiary of Sotera Health Co., Reaches $34 Million Settlement in Willowbrook EO Claims

Reuters
24 Jul
Sterigenics, a Subsidiary of Sotera Health Co., Reaches $34 Million Settlement in Willowbrook EO Claims

Sterigenics U.S., LLC, a subsidiary of Sotera Health Company, has reached a binding term sheet agreement to resolve 129 ethylene oxide claims related to its former facility in Willowbrook, Illinois. The settlement includes ten claims set for trials in the Circuit Court of Cook County in 2025 and 2026, as well as other claims from an additional 119 claimants. As part of the agreement, Sterigenics will pay $34 million, and the plaintiffs' claims will be dismissed with prejudice. The settlement process is anticipated to take 60 to 90 days and requires several conditions to be met, including full claimant participation and a good faith determination by the court. Sterigenics denies any liability, and the settlement is not to be interpreted as an admission of safety hazards from the facility's emissions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sotera Health Co. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001822479-25-000036), on July 24, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10